Ontology highlight
ABSTRACT:
SUBMITTER: Chiocca EA
PROVIDER: S-EPMC7195500 | biostudies-literature | 2020 Jun
REPOSITORIES: biostudies-literature
Chiocca E Antonio EA Nakashima Hiroshi H Kasai Kazue K Fernandez Soledad A SA Oglesbee Michael M
Molecular therapy. Methods & clinical development 20200330
rQNestin34.5v.2 is an oncolytic herpes simplex virus 1 (oHSV) that retains expression of the neurovirulent ICP34.5 gene under glioma-selective transcriptional regulation. To prepare an investigational new drug (IND) application, we performed toxicology and efficacy studies of rQNestin34.5v.2 in mice in the presence or absence of the immunomodulating drug cyclophosphamide (CPA). ICP34.5 allows HSV1 to survive interferon and improves viral replication by dephosphorylation of the eIF-2α translation ...[more]